James Lind Care is a clinical trial patient recruitment company serving mainly pharmaceutical companies and clinical research organizations. Its goal is to connect patients with clinical research and help sponsors address insufficient enrollment or trial delays. According to the website, the company was founded in 2011. It is positioned not as a general-purpose enterprise SaaS product, but more as a specialized, service-led patient recruitment solution.
Its core capabilities include patient recruitment, patient screening, referral of qualified patients to study sites, and reducing the enrollment burden on sites. Case studies on the website show that in one Phase III type 2 diabetes trial, James Lind Care delivered 26 randomized enrollments within 3 months, helping the trial avoid delays. In another Phase III cardiovascular HFpEF trial, 57 screened patients resulted in 24 randomized enrollments, a randomization rate of 42%. Site feedback also emphasizes the quality of screening by its research nurses, enabling study centers to manage patients without being overwhelmed by large numbers of unqualified referrals.
The website does not disclose plans, pricing, billing models, free trials, or standard contract information, so quotes are likely provided on a project-by-project basis. From a SaaS or enterprise software perspective, information transparency is limited: there is no clear mention of dashboards, permission management, team collaboration, APIs, developer documentation, third-party system integrations, cloud deployment, or self-hosting. On the data side, the terms page mentions a defined data processing policy and careful prevention of information misuse, but it does not disclose specific security certifications, privacy compliance frameworks, or cross-border data processing details.
The strengths are its vertical focus, clear service objective, and reasonably persuasive case studies. It also emphasizes collaboration with pharmaceutical companies, CROs, research institutions, patient organizations, and study sites, making it suitable for complex clinical projects. The drawbacks are that the website shows limited productization and lacks key information on pricing, platform capabilities, security and compliance, integrations, and local support in China. Buyers will need to conduct substantial due diligence before procurement.
James Lind Care is better suited to pharmaceutical companies, CROs, research institutions, and clinical trial sponsors, especially for projects facing recruitment delays, requiring patients with specific diseases, or needing multinational recruitment support. The main content does not provide information on access from China, and supported payment methods are also unknown. If running projects in China, sponsors should confirm whether it has the ability to reach Chinese patients and meet local ethics and data compliance requirements. Alternatives to evaluate include global CRO patient recruitment services and domestic clinical operations service providers.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on jameslindcare.com official site.
jameslindcare.com is an United Kingdom SaaS Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach jameslindcare.com directly.